P. Caldwell, S. Murphy, P. Butow, and J. Craig, Clinical trials in children, The Lancet, vol.364, issue.9436, pp.803-814, 2004.
DOI : 10.1016/S0140-6736(04)16942-0

N. Mcintosh, P. Bates, G. Brykczynska, G. Dunstan, A. Goldman et al., Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics, Child Health: Ethics Advisory Committee, Arch Dis Child, vol.82, pp.177-82, 2000.

R. Steinbrook, Testing Medications in Children, New England Journal of Medicine, vol.347, issue.18, pp.1462-70, 2002.
DOI : 10.1056/NEJMhpr021646

N. Sung, C. Jr, W. Genel, M. Salber, P. Sandy et al., Central Challenges Facing the National Clinical Research Enterprise, JAMA, vol.289, issue.10, pp.1278-87, 2003.
DOI : 10.1001/jama.289.10.1278

B. Osuntokun, Clinical trials in pediatrics: The drug delivery dimension???, Advanced Drug Delivery Reviews, vol.58, issue.1, pp.90-105, 2006.
DOI : 10.1016/j.addr.2005.12.004

J. Li, E. Eisenstein, H. Grabowski, E. Reid, B. Mangum et al., Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program, JAMA, vol.297, issue.5, pp.480-488, 2007.
DOI : 10.1001/jama.297.5.480

E. Cohen, E. Uleryk, M. Jasuja, and P. Parkin, An absence of pediatric randomized controlled trials in general medical journals, 1985???2004, Journal of Clinical Epidemiology, vol.60, issue.2, pp.118-141, 2007.
DOI : 10.1016/j.jclinepi.2006.03.015

D. Thomson, L. Hartling, E. Cohen, B. Vandermeer, L. Tjosvold et al., Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published, PLoS ONE, vol.5, 1948.

G. Pons, La mise en??place en??Europe des??r??seaux d'investigation des??m??dicaments chez??l'enfant, Archives de P??diatrie, vol.13, issue.6, p.631, 2006.
DOI : 10.1016/j.arcped.2006.03.093

P. Auby, Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective, Child and Adolescent Psychiatry and Mental Health, vol.2, issue.1, p.38, 2008.
DOI : 10.1001/jama.297.5.480

T. Olski, S. Lampus, G. Gherarducci, S. Raymond, and A. , Three years of paediatric regulation in the European Union, European Journal of Clinical Pharmacology, vol.3, issue.S2, pp.245-52, 2011.
DOI : 10.1007/s00228-011-0997-4

C. Milne and J. Davis, The Pediatric Studies Initiative: After 15 Years Have We Reached the Limits of the Law?, Clinical Therapeutics, vol.36, issue.2, pp.156-62, 2014.
DOI : 10.1016/j.clinthera.2013.11.007

J. Corny, D. Lebel, B. Bailey, and J. Bussières, Unlicensed and Off-Label Drug Use in Children Before and After Pediatric Governmental Initiatives, J Pediatr Pharmacol Ther, vol.20, pp.316-344, 2015.

F. Bourgeois, K. Olson, J. Ioannidis, and K. Mandl, Association Between Pediatric Clinical Trials and Global Burden of Disease, PEDIATRICS, vol.133, issue.1, pp.78-87, 2014.
DOI : 10.1542/peds.2013-2567

I. Boots, R. Sukhai, R. Klein, R. Holl, J. Wit et al., Stimulation programs for pediatric drug research ??? do children really benefit?, European Journal of Pediatrics, vol.58, issue.Suppl 2, pp.849-55, 2007.
DOI : 10.1007/s00431-006-0381-z

C. Yang, M. Veltri, A. B. Yaster, M. Berkowitz, and I. , Food and Drug Administration approval for medications used in the pediatric intensive care unit: A continuing conundrum, Pediatric Critical Care Medicine, vol.12, issue.5, pp.195-204, 2011.
DOI : 10.1097/PCC.0b013e3181fe25b9

C. Milne and J. Bruss, The economics of pediatric formulation development for off-patent drugs, Clinical Therapeutics, vol.30, issue.11, pp.2133-2178, 2008.
DOI : 10.1016/j.clinthera.2008.11.019

J. Osborne, O. Callaghan, and F. , Running an international paediatric non-commercial clinical trial, Archives of Disease in Childhood, vol.94, issue.9, pp.729-762, 2009.
DOI : 10.1136/adc.2008.148494

D. Girard, O. Bourdon, H. Abdoul, S. Prot-labarthe, F. Brion et al., How to Improve the Implementation of Academic Clinical Pediatric Trials Involving Drug Therapy? A Qualitative Study of Multiple Stakeholders, PLoS ONE, vol.48, issue.5, p.64516, 2013.
DOI : 10.1371/journal.pone.0064516.s002

B. Gordon, A. Kessinger, S. Mann, and E. Prentice, The impact of escalating regulatory requirements on the conduct of clinical research, Cytotherapy, vol.5, issue.4, pp.309-322, 2003.
DOI : 10.1080/14653240310002225

C. Berlin-jr, Challenges in conducting pediatric drug trials, Journal of Allergy and Clinical Immunology, vol.106, issue.3, pp.125-132, 2000.
DOI : 10.1067/mai.2000.109418

A. Henry, S. Corvaisier, S. Blanc, F. Berthezene, F. Borson-chazot et al., Perception des essais cliniques par les patients et les investigateurs : revue bibliographique (1re partie), Th??rapie, vol.61, issue.5, pp.425-462, 2006.
DOI : 10.2515/therapie:2006072

E. Kemper, M. Merkus, P. Wierenga, P. Van-rijn, D. Van-der-werff et al., Towards evidence-based pharmacotherapy in children, Pediatric Anesthesia, vol.19, issue.1 Pt 1, pp.183-192, 2011.
DOI : 10.1111/j.1460-9592.2010.03493.x
URL : https://hal.archives-ouvertes.fr/hal-00604055

E. Schirm, H. Tobi, T. De-vries, I. Choonara, D. Jong-van-den et al., Lack of appropriate formulations of medicines for children in the community, Acta Paediatrica, vol.104, issue.3, pp.1486-1495, 2003.
DOI : 10.1111/j.1651-2227.2003.tb00837.x

T. Nunn and J. Williams, Formulation of medicines for children, British Journal of Clinical Pharmacology, vol.179, issue.4, pp.674-680, 2005.
DOI : 10.1111/j.1365-2125.2005.02410.x

A. Zajicek, The National Institutes of Health and the Best??Pharmaceuticals for Children Act, Pediatric Drugs, vol.1053, issue.4, pp.45-52, 2009.
DOI : 10.2165/0148581-200911010-00015

F. Zannad and Y. Plétan, Difficulties with conducting clinical trials in France, Therapie, vol.56, pp.341-348, 2001.

E. Lader, C. Cannon, E. Ohman, L. Newby, D. Sulmasy et al., The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting: Appendix 1: Fundamentals of Study Design, Circulation, vol.109, issue.21, pp.302-306, 2004.
DOI : 10.1161/01.CIR.0000128807.57602.61

M. Ward, Myths and realities in clinical research, Journal of Gastroenterology and Hepatology, vol.303, issue.9, pp.887-91, 1996.
DOI : 10.1016/0140-6736(93)92055-X

E. Campbell, J. Weissman, E. Moy, and D. Blumenthal, Status of Clinical Research in Academic Health Centers, JAMA, vol.286, issue.7, pp.800-806, 2001.
DOI : 10.1001/jama.286.7.800

K. Dainty and J. Karlsson, Factors to consider in determining the feasibility of randomized clinical trials, Arthroscopy: The Journal of Arthroscopic & Related Surgery, vol.19, issue.8, pp.882-886, 2003.
DOI : 10.1016/S0749-8063(03)00707-2

L. Welzing, U. Harnischmacher, A. Weyersberg, and B. Roth, Consequences of DirectiveEC for investigator-initiated trials in the paediatric population?a field report, Eur J Pediatr, vol.20166, pp.1169-76, 2001.

. Home-clinicaltrials, gov [Internet] Available from: https://clinicaltrials.gov, 2016.

H. Hemingway, R. Riley, and D. Altman, Ten steps towards improving prognosis research, BMJ, vol.339, issue.dec30 1, p.4184, 2009.
DOI : 10.1136/bmj.b4184

C. Development and . Team, R: A language and environment for statistical computing Austria: R Foundation for Statistical Computing V, 2008.

J. Demotes-mainard, E. Canet, and L. Segard, Public-Private Partnership Models in France and in Europe, Th??rapie, vol.61, issue.4, pp.325-359, 2006.
DOI : 10.2515/therapie:2006059

J. Martin and D. Kasper, In Whose Best Interest? Breaching the Academic???Industrial Wall, New England Journal of Medicine, vol.343, issue.22, pp.1646-1655, 2000.
DOI : 10.1056/NEJM200011303432213

. La-recherche,-un-enjeu-majeur-pour-l-'ap-hp and . Internet, Available from: http://rechercheclinique.aphp.fr/La-recherche-un-enjeu-majeur-pour-l-AP-HP. html?article&lang=fr&dir=ltr

W. Schlaff, H. Zhang, M. Diamond, C. Coutifaris, P. Casson et al., Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies, Fertility and Sterility, vol.96, issue.1, pp.15-23, 2011.
DOI : 10.1016/j.fertnstert.2011.05.069

R. Wasserman, A. Bocian, D. Harris, and E. Slora, Limited Capacity in US Pediatric Drug Trials, Pediatric Drugs, vol.50, issue.2, pp.119-143, 2011.
DOI : 10.2165/11584240-000000000-00000

F. Rocchi and P. Tomasi, The development of medicines for children, Pharmacological Research, vol.64, issue.3, pp.169-75, 2011.
DOI : 10.1016/j.phrs.2011.01.016

S. Pandit, U. Shah, D. Kirby, T. Nunn, and C. Tuleu, Inappropriate oral formulations and information in paediatric trials, Archives of Disease in Childhood, vol.95, issue.9, pp.754-760, 2010.
DOI : 10.1136/adc.2009.175661

V. Ivanovska, C. Rademaker, L. Van-dijk, and A. Mantel-teeuwisse, Pediatric Drug Formulations: A Review of Challenges and Progress, PEDIATRICS, vol.134, issue.2, 2014.
DOI : 10.1542/peds.2013-3225

T. Ernest, J. Craig, A. Nunn, S. Salunke, C. Tuleu et al., Preparation of medicines for children ??? A hierarchy of classification, International Journal of Pharmaceutics, vol.435, issue.2, pp.124-154, 2012.
DOI : 10.1016/j.ijpharm.2012.05.070